¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gradient echo technique magnetic susceptibility pro"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • echo amplitude
    ¸Þ¾Æ¸®Å©±â, ¿¡ÄÚÅ©±â
  • echo diplacusis
    ¸Þ¾Æ¸®°ãµè±â, ¹ÝÇ⺹û
  • echo intensity
    ¸Þ¾Æ¸®°­µµ
  • echo pulse
    ÃÊÀ½ÆÄ, ¸Þ¾Æ¸®ÆÄ
  • echo sign
    ¸Þ¾Æ¸®Â¡ÈÄ
  • fast spin echo
    °í¼Ó½ºÇÉ¿¡ÄÚ
  • hepatorenal echo contrast
    °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶, °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • homogeneous echo pattern
    ±ÕÁú¸Þ¾Æ¸®¾ç»ó
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
  • odd echo dephasing
    Ȧ¼ö¿¡ÄÚÅ»À§»ó
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • reverberation echo
    ¹ÝÇâ¸Þ¾Æ¸®, ¹ÝÇâ¿¡ÄÚ
  • spin echo
    ½ºÇÉ¿¡ÄÚ
  • spin echo imaging
    ½ºÇÉ¿¡ÄÚ¿µ»ó
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • host susceptibility
    ¼÷ÁÖ°¨¼ö¼º
  • hypnotic susceptibility
    Ãָ鰨¼ö¼º
  • mass susceptibility
    Áú·®¹Î°¨µµ
  • molar susceptibility
    ¸ô´ç·®°¨¼ö¼º
  • susceptibility
    °¨¼ö¼º
  • susceptibility test
    °¨¼ö¼º½ÃÇè
  • echo amplitude
    ¸Þ¾Æ¸®Å©±â, ¿¡ÄÚÅ©±â
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
  • capsular echo
    ÇǸ·¸Þ¾Æ¸®, ÇǸ·¿¡ÄÚ
  • central echo complex
    Á߽ɹÝÇ⺹ÇÕü, Á߽ɸ޾Ƹ®º¹ÇÕü
  • complex echo pattern
    º¹Àâ¸Þ¾Æ¸®, º¹ÇÕ¿¡ÄÚ¾ç»ó
  • hepatorenal echo contrast
    °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶, °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶
  • echo diplacusis
    ¸Þ¾Æ¸®°ãµè±âÁõ, ¹ÝÇ⺹û
  • odd echo dephasing
    Ȧ¼ö¿¡ÄÚÅ»À§»óÈ­
  • echo
    ¸Þ¾Æ¸®, ¹ÝÇâ, ¿¡ÄÚ, ÃÊÀ½ÆÄ-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • high echo area
    °í ¿¡ÄÚ ±¸¿ª
  • high echo area
    °í (ÍÔ) ¿¡ÄÚ ¿ª (æ´)
  • posterior echo
    ÈÄ¹æ ¿¡ÄÚ
  • posterior echo
    ÈĹæ (ý­Û°) ¿¡ÄÚ
  • posterior echo enhancement
    ÈÄ¹æ ¿¡ÄÚ Áõ°­, ÈÄ¹æ ¸Þ¾Æ¸®Áõ°­
  • posterior echo enhancement
    ÈĹæ (ý­Û°) ¿¡ÄÚ Áõ°­ (ñòË­), ÈĹæ (ý­Û°) ¸Þ¾Æ¸® ?
  • posterior wall echo
    Èĺ® ¿¡ÄÚ
  • posterior wall echo
    Èĺ® (ý­Ûú) ¿¡ÄÚ
  • pulse echo principle
    ÆÞ½º ¿¡ÄÚ ¿ø¸®
  • pulse echo principle
    ÆÞ½º-¿¡ÄÚ ¿ø¸® (ê«×â)
  • pulse echo techinique
    ÆÞ½º-¿¡ÄÚ ±â¹ý (ÐüÛö)
  • B1 field gradient
    ȸÀü ÀÚÀå Àڱ⠰æ»ç
  • Ficoll-Hypaque gradient centrifugation
    ÇÇÄÝ-ÇÏÀÌÆÑ ¹Ðµµ±¸¹è ¿ø½ÉºÐ¸®
  • Ion gradient
    À̿°æ»ç(ÌËÞØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulse-echo technique
    ÆÞ½º-¿¡ÄÚ ±â¹ý (ÐüÛö)
  • simulated echo technique
    ¸ðÀÇ ¿¡ÄÚ ±â¹ý
  • spin echo technique
    ½ºÇÉ ¿¡ÄÚ±â¹ý
  • antifungal susceptibility testing
    Ç×Áø±Õ°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility testing
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè¹ý
  • atomic susceptibility
    ¿øÀÚÀÚÈ­À² (¡­í¸ûùëÒ).
  • colo(u)rimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼º ºñ»ö½ÃÇè(ó»ãÝÊïáô àõÝïßäãËúÐ).
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disk dilution susceptibility test
    µð½ºÅ©Èñ¼®°¨¼ö¼º½ÃÇè
  • ether susceptibility
    ¿¡Å׸£°¨¼ö¼º (¿ÜÇǺ¸À¯¹ÙÀÌ·¯½ºÀÇ)
  • genetic susceptibility
    À¯ÀüÀÚ°¨¼ö¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • density gradient zonal centrifugation
    "¹Ðµµ±¸¹è ¿ª¿ø½ÉºÐ¸®(ÚËÓøÎþÛÕæ´êÀãýÝÂ×î), (ÔÒ) density gradient sedimentation velocity"
  • direct fluorescent antibody technique
    Á÷Á¢ Çü±¤ Ç×ü¼ú(òÁïÈû«ÎÃù÷ô÷âú)
  • discontinuous density gradient
    ºÒ¿¬¼Ó ¹Ðµµ±¸¹è(ÝÕææáÙÚËÓøÎþÛÕ)
  • DNA-agar technique
    DNAÇÑõ(ùÎô¸) ¼ú(âú)
  • double-blind technique
    ÀÌÁ߸Ͱ˼ú(ì£ñìØîËþâú)
  • double-well technique
    ÀÌÁ¤¼ú(ì£ïÌâú)
  • everted sac technique
    ¿Ü¹ø³¶¼ú(èâÛèÒ¥âú)
  • exponential density gradient
    Áö¼ö ³óµµ ±¸¹è (ò¦â¦ÒØÓøÎøÛÎ)
  • FICA technique
    FICA ¼ú(âú)
  • fluidity gradient
    À¯µ¿¼º ±¸¹è(×µÔÑàõÎþÛÕ)
  • fluorescent antibody technique
    Çü±¤ Ç×ü¼ú(û«ÎÃù÷ô÷âú)
  • freeze-clamp technique
    ¾ó¸² Ŭ·¥ÇÁ ¼ú(âú)
  • freeze-stop technique
    ¾ó¸²Á¤Áö(ïÎò­) ¼ú(âú)
  • gradient
    ±¸¹è(ÎþÛÕ)
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulsed gradient spin echo (PGSE)
    ÆÞ½º°æ»ç½ºÇÉ¿¡ÄÚ
  • multi echo stimulated echo acquisition
    ´ÙÁß¿¡ÄÚÀڱؿ¡ÄÚȸµæ
  • mass susceptibility
    Áú·®¹Î°¨µµ
  • molar susceptibility
    ¸ô´ç·®°¨¼ö¼º
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
  • susceptibility
    °¨¼ö¼º, ÀÌȯ¼º, ÀÚÈ­À²
  • susceptibility artifact
    ÀÚÈ­À²Àΰø¹°, °¨¼ö¼ºÀΰøÀ½¿µ
  • susceptibility distortions
    ÀÚÈ­À²¿Ö°î
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • broadband transmission technique
    ±¤ÆøÁ֯ļöÀüÆÄ±â¼ú
  • coaxial technique
    µ¿Ãà±â¹ý
  • dephase-rephase technique
    Å»À§»ó-ÀçÀ§»ó±â¹ý
  • Dixon technique
    Dixon ¹ý
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FEER field echo with even echo rephasing
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
SPT secretin-pancreazymin [test]; single patch technique; sleep period time; spectrin; station pull-thro...
B0 constant magnetic field in nuclear magnetic resonance
Bo constant magnetic field in a magnetic resonance scanner
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
pro-NPY Pro-neuropeptide Y
pro-TRH Pro-thyrotrophin-releasing hormone
pro-CCK pro-cholecystokinin
pro-enk pro-enkephalin
pro-enk A pro-enkephalin A
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Z gradient
    ZÃà °æ»ç
  • cine cardiac magnetic resonance imaging
    ¿µÈ­ ½ÉÀå Àڱ⠰ø¸í ¿µ»ó
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • magnetic attraction
    ÀÚ±â ÀηÂ
  • magnetic circuit
    ÀÚ±â ȸ·Î
  • magnetic coil
    ÀÚ±â ÄÚÀÏ, ÀÚ¼º ÄÚÀÏ
  • magnetic dipole
    Àڱ⠽ֱØÀÚ, ÀÚ¼º ½Ö±ØÀÚ
  • magnetic disk
    Àڱ⠵ð½ºÅ©
  • magnetic electricity
    ÀÚÀü±â
  • magnetic field intensity
    ÀÚÀå °­µµ
  • magnetic flux density
    ÀÚ±â À¯µ¿ ¹Ðµµ
  • magnetic fringe field
    ÀÚ±â ÁÖº¯ ÀÚÀå
  • magnetic induction
    ÀÚ±â À¯µµ
  • magnetic influence
    Àڱ⠰¨ÀÀ ÀÛ¿ë
  • magnetic isocentre
    Àڱ⠵¿½É
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
pro-opiomelanocortin <chemical> A precursor protein, mw 30,000, synthesised mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of acth and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides msh, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin.
Chemical name: Opiomelanocortin, pro-
(12 Dec 1998)
pro-oxidants Compounds or agents capable of generating toxic oxygen species.
Compare: antioxidant.
(05 Mar 2000)
pro re nata As the occasion arises; as necessary.
Acronym: prn
Origin: L.
(05 Mar 2000)
pro-transforming growth factor-alpha processing protease <enzyme> Converts membrane-bound protgf-alpha to soluble tgf-alpha; mw 84 kD
Registry number: EC 3.4.21.-
Synonym: protgf-alpha converting enzyme, protgfalpha processing protease
(26 Jun 1999)
X-Pro aminopeptidase <enzyme> Proline specific exopeptidase
Registry number: EC 3.4.11.9
Synonym: x-prolyl aminopeptidase, proline-specific exopeptidase, aminopeptidase p
(26 Jun 1999)
atrioventricular gradient The diastolic pressure difference between the atrium and ventricle.
(05 Mar 2000)
ventricular gradient The algebraic sum of (i.e., the net electrical difference between) the area enclosed within the QRS complex and that within the T wave in the electrocardiogram.
(05 Mar 2000)
voltage gradient <physiology> Literally, the electric field in a region, defined as the potential difference between two points divided by the distance between them. Used more loosely, the potential difference across a plasma membrane.
(18 Nov 1997)
centrifugation, density gradient Separation of particles according to density by employing a gradient of varying densities. at equilibrium each particle settles in the gradient at a point equal to its density.
(12 Dec 1998)
cesium chloride gradient centrifugation A type of density gradient centrifugation, a lab technique used to separate or purify nucleic acids. It involves putting cesium chloride and the nucleic acids into a centrifuge to be spun for hours or days. The cesium chloride forms a density gradient (highly dense at the bottom, thinnest at the top), and the different nucleic acids separate along the gradient according to their buoyancies in different densities.
(09 Oct 1997)
gradient <physics> Mathematical term for the operator which determines the magnitude and direction of the greatest rate-of-change of a given function with position. Similarly used to describe such a rate-of-change.
For instance, at a given point on a hill, the slope of the hill in the steepest uphill direction is the gradient of the altitude function for the hill.
(09 Oct 1997)
gradient elution Elution in column chromatography in which a changing pH or ionic strength is used to separate substances.
(05 Mar 2000)
gradient encoding In magnetic resonance imaging, the technique of inducing a gradient in the magnetic field in the Y-axis to induce phase differences with location.
Synonym: gradient encoding.
(05 Mar 2000)
gradient perception <cell biology> Problem faced by a cell that is to respond directionally to a gradient of, for example: a diffusible attractant chemical.
In a spatial mechanism the cell would compare receptor occupancy at different sites on the cell surface, a temporal mechanism would involve comparison of concentrations at different times, the cell moving randomly between readings.
In pseudospatial sensing, the cell would detect the gradient as a consequence of positive feedback to protrusive activity if receptor occupancy increased with time as the protrusion moved up gradient. Few cell types have been unambiguously shown to detect gradients.
(18 Nov 1997)
mitral gradient The diastolic pressure difference between the left atrium and left ventricle.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • magnetic
    ÀÚ±â
  • magnetic
    Àڱ⼺ÀÌ ÀÖ´Â;¸Å·Â ÀÖ´Â
  • magnetic (dipole) moment
    Àڱ⠽ְîÀÚ ¸ð¸àÆ®;Àڱ⠸ð¸àÆ®
  • magnetic bubble
    Æ÷ÀÚ±¸(ÀÚ¼ºÀç ¾È¿¡ ³ªÅ¸³ª´Â ¿øÁÖ²ÃÀÇ ÀÚ±¸)
  • magnetic card
    ÀÚ±â Ä«µå
  • magnetic circuit
    ÀÚ±â ȸ·Î
  • magnetic compass
    ÀÚ±â ÄÄÆÛ½º(³ªÄ§ÀÇ)
  • magnetic core
    (ÄÄÇ»ÅÍ) ÀÚ±â ÄÚ¾î(±â¾ï ¼ÒÀÚ·Î ¾²ÀÌ´Â ÀÚöÀÇ ÀÛÀº °í¸®)
  • magnetic declination
    ÀÚ±â Æí°¢
  • magnetic detector
    ÀÚ±â °ËÆÄ±â
  • magnetic disk
    Àڱ⠵ð½ºÅ©(Ç¥¸éÀÌ ÀÚ¼º Àç·á·Î µ¤Èù ¿øÆÇ»óÀÇ ±â·Ï ¸Åü)
  • magnetic domain
    (°­ÀÚ¼ºÃ¼ÀÇ) ÀÚ±¸
  • magnetic drum
    Àڱ⠵巳
  • magnetic equator
    ÀÚ±â Àûµµ
  • magnetic exploration
    Àڱ⠎±¤(¹ý)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á